Premium
Cancer Treatment: Development of a Dual‐Modally Traceable Nanoplatform for Cancer Theranostics Using Natural Circulating Cell‐Derived Microparticles in Oral Cancer Patients (Adv. Funct. Mater. 40/2017)
Author(s) -
Yu ZiLi,
Zhang Wei,
Zhao JingYa,
Zhong WenQun,
Ren JianGang,
Wu Min,
Zhang ZhiLing,
Pang DaiWen,
Zhao YiFang,
Chen Gang
Publication year - 2017
Publication title -
advanced functional materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.069
H-Index - 322
eISSN - 1616-3028
pISSN - 1616-301X
DOI - 10.1002/adfm.201770235
Subject(s) - cancer , materials science , nanotechnology , cancer cell , dual (grammatical number) , quantum dot , cancer research , medicine , art , literature
A dual‐modally traceable nanoplatform for tumor theranostics is developed by Gang Chen and co‐workers in article number 1703482 . Circulating cell‐derived microparticles isolated from the peripheral blood of oral cancer patients are transformed into a tumor‐targeted and traceable nanoplatform encapsulating antitumor siRNA and NIR‐fluorescent magnetic quantum dots (QDs). This strategy opens new avenues for the development of real natural nanoplatforms for personalized cancer theranostics.